Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view

S Craig, JL Pépin, W Randerath… - European …, 2022 - Eur Respiratory Soc
Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA),
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …

Positive airway pressure adherence, mortality, and cardiovascular events in patients with sleep apnea

C Gervès-Pinquié, S Bailly, F Goupil… - American Journal of …, 2022 - atsjournals.org
Rationale: Randomized controlled trials showed no effect of positive airway pressure (PAP)
therapy for obstructive sleep apnea (OSA) on cardiovascular (CV) risk. However, patient …

Obstructive sleep apnea and cardiovascular diseases: sad realities and untold truths regarding care of patients in 2022

SP Gunta, RS Jakulla, A Ubaid… - Cardiovascular …, 2022 - Wiley Online Library
Obstructive sleep apnea (OSA) is one of the most common and serious sleep‐related
breathing disorders with a high prevalence among patients with cardiovascular (CV) …

All-cause mortality in people with co-occurring insomnia symptoms and sleep apnea: analysis of the Wisconsin Sleep Cohort

B Lechat, KA Loffler, DM Wallace… - Nature and Science …, 2022 - Taylor & Francis
Purpose Insomnia symptoms and sleep apnea frequently co-occur and are associated with
worse sleep, daytime function, mental health and quality of life, compared to either insomnia …

Association of obstructive sleep apnea and opioids use on adverse health outcomes: a population study of health administrative data

T Kendzerska, T Gomes, A Malhotra, AS Gershon… - PloS one, 2022 - journals.plos.org
Rationale Despite the high prevalence of obstructive sleep apnea (OSA) and concurrent use
of opioid therapy, no large-scale population studies have investigated whether opioid use …

L-Citrulline supplementation reduces blood pressure and myocardial infarct size under chronic intermittent hypoxia, a major feature of sleep apnea syndrome

B Ozcan, B Blachot-Minassian, S Paradis, L Mazière… - Antioxidants, 2022 - mdpi.com
Intermittent hypoxia (IH) is a landmark of obstructive sleep apnea (OSA) at the core of the
cardiovascular consequences of OSA. IH triggers oxidative stress, a major underlying …

Impact of a weight-loss rehabilitation program on sleep apnea risk and subjective sleepiness in patients with overweight/obesity: The Dietsleep study

S Bailly, O Fabre, M Cals-Maurette, L Pantagis… - Journal of Clinical …, 2022 - mdpi.com
Obstructive sleep apnea (OSA) is one of the most frequent chronic diseases, and comorbid
obesity occurs in more than 60% of cases. Variations in body weight influence both OSA …

Obtaining valid estimates of the effect of CPAP therapy: reducing healthy adherer and other biases in observational studies

VK Kapur, BM Psaty - Chest, 2022 - journal.chestnet.org
Randomized controlled trials (RCTs) treating OSA with CPAP have demonstrated
improvements for outcomes that can be assessed over the short-term, including improved …

Using Real-World Data to Understand Who Has Cardiovascular Benefits from Continuous Positive Airway Pressure: The Importance of Male Sex, Excessive …

BT Keenan, R Heinzer - … Journal of Respiratory and Critical Care …, 2022 - atsjournals.org
8. Lindstrand A, Galanis I, Darenberg J, Morfeldt E, Naucler P, Blennow M, et al. Unaltered
pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive …

[PDF][PDF] From patient-centric personalized approach in sleep medicine–From theory to practice

O Vanderveken - J Dent Sleep Med, 2022 - researchgate.net
A large majority of patients with obstructive sleep apnea (OSA) are currently treated with a
device-therapy, such as continuous positive airway pressure (CPAP), mandibular …